Transaction · 0000914190-26-000113

Herr Amy E.

Herr Amy E., DIR, reported a transaction classified as exercise at BIO-TECHNE Corp involving 118.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MDIR
TECHBIO-TECHNE Corp
Trade date
Aug 15, 2026
Filing date
Aug 18, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded118$0.00 per share
Holdings after0Indirect · By significant other
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.6%1w ago +0.1%1d ago +0.2%
Returns since7d +0.2%30d +0.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0000914190-26-000113
Restricted Stock Units
Transaction date
Aug 15, 2026
Filed Aug 18, 2026, 08:12 PM · 3d delay
Shares
118 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Indirect · By significant other

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.

  2. F2

    Fully vested.

  3. F3

    Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.

  4. F4

    Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.

  5. F5

    Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

  6. F6

    Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.

  7. F7

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

  8. F8

    118 restricted stock units vest on 8/15/2026.

  9. F9

    160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

  10. F10

    38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028.

  11. F11

    311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.

  12. F12

    Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.

Original filing · 0000914190-26-000113
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH